The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relative bioavailability (BA) and bioequivalence (BE) study of abiraterone acetate (AA) fine particle (AAFP) with methylprednisolone (MP) and a reference formulation with prednisone (PN) in healthy male subjects.
 
Azra Hussaini
No Relationships to Disclose
 
Anthony J. Olszanski
Consulting or Advisory Role - Bristol-Myers Squibb; G1 Therapeutics; Kyowa Hakko Kirin; Merck; Takeda
Research Funding - Advaxis (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ignyta (Inst); Immunocore (Inst); Incyte (Inst); Kura Oncology (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Churchill Pharmaceuticals; G1 Therapeutics; Kyowa Hakko Kirin; Takeda
 
Cy Aaron Stein
Honoraria - Medivation; Sanofi
Consulting or Advisory Role - Churchill Pharmaceuticals; Roche
Speakers' Bureau - Medivation; Sanofi
Research Funding - Roche
Patents, Royalties, Other Intellectual Property - City of Hope
 
Bill Bosch
Employment - Churchill Pharmaceuticals; iCeutica
Leadership - Churchill Pharmaceuticals; iCeutica
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Merck; Pfizer; United Health Corp
Expert Testimony - Teva Innovation Canada
Travel, Accommodations, Expenses - Churchill Pharmaceuticals; iCeutica
 
Paul Nemeth
Employment - Churchill Pharmaceuticals
Stock and Other Ownership Interests - AstraZeneca; Johnson & Johnson; Lilly; Pfizer